Embecta (EMBC) Current Assets (2021 - 2026)
Embecta (EMBC) posted Current Assets of $608.1 million for Q1 2026, down 1.95% sequentially from $620.2 million in Q4 2025, and down 5.49% YoY from $643.4 million in Q1 2025.
Embecta (EMBC) Current Assets (2021 - 2026) Analysis & Trends
Embecta has reported Current Assets for 6 years, with the latest figure at $608.1 million in Q1 2026.
- Quarterly Current Assets fell 5.49% year-over-year to $608.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $608.1 million (down 5.49% YoY) and the FY2025 annual result came in at $631.4 million, down 17.03% from the prior year.
- Current Assets retreated to $608.1 million in Q1 2026 per EMBC's latest filing, from $620.2 million in the prior quarter.
- Over five years, Current Assets peaked at $787.5 million in Q2 2023 and troughed at $426.5 million in Q1 2022.
- A 5-year average of $679.4 million and a median of $681.5 million in 2025 frame the typical range for Current Assets.
- The sharpest annual moves came in 2022 and 2025: Current Assets soared 194.89% in 2022, then decreased 17.03% in 2025.
- Over 5 years, Current Assets stood at $761.7 million in 2022, then decreased by 5.54% to $719.5 million in 2023, then decreased by 7.27% to $667.2 million in 2024, then decreased by 7.04% to $620.2 million in 2025, then declined by 1.95% to $608.1 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $608.1 million, $620.2 million, and $631.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 9.54 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 8.14 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 6.62 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 4.32 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 11.74 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 1.81 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 3.74 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 2.30 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 6.99 Bn |
| 10 | Embecta | 305.26 Mn | 87.06 Mn | 153.30 Mn | 705.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 705.10 Mn |
| Mar 31, 2026 | 608.10 Mn |
| Dec 31, 2025 | 620.20 Mn |
| Sep 30, 2025 | 631.40 Mn |
| Jun 30, 2025 | 681.50 Mn |
| Mar 31, 2025 | 643.40 Mn |
| Dec 31, 2024 | 667.20 Mn |
| Sep 30, 2024 | 761.00 Mn |
| Jun 30, 2024 | 781.10 Mn |
| Mar 31, 2024 | 710.00 Mn |
| Dec 31, 2023 | 719.50 Mn |
| Sep 30, 2023 | 749.10 Mn |
| Jun 30, 2023 | 787.50 Mn |
| Mar 31, 2023 | 756.30 Mn |
| Dec 31, 2022 | 761.70 Mn |
| Sep 30, 2022 | 664.70 Mn |
| Jun 30, 2022 | 580.60 Mn |
| Mar 31, 2022 | 426.50 Mn |
| Dec 31, 2021 | 258.30 Mn |
| Sep 30, 2021 | 291.80 Mn |